K9-LiquiDX Canine Cancer Check

This is the world’s first minimal residual disease (MRD) test specifically tailored for dogs. This cutting-edge, liquid biopsy-based tool offers a noninvasive, reliable solution for early diagnosis and cancer relapse detection, revolutionizing how veterinarians approach cancer care.

Vet Expert K9-LiquiDX Canine Cancer Check test result is then presented in the form of a detailed report, offering valuable insights for early diagnosis, treatment planning, and monitoring of cancer progression or relapse.

• EARLY DETECTION: Detect cancer and potential relapses before they show clinical signs.
• EARLY INTERVENTION: Initiate treatment earlier for better outcomes and prolonged quality of life.
• PRECISION MONITORING: High-precision results enable targeted, personalized treatment strategies based on each animals genetic profile.
• COMPREHENSIVE FINAL REPORT: Access detailed genetic data that ensures more accurate and effective treatment plans.
• NO SEDATION REQUIRED: Most patients can undergo the procedurę with no sedation or anesthesia.
• ADVANCED CARE: Position your clinic at the forefront of veterinary medicine by offering this innovative, minimally-invasive cancer detection technology.
• IMPROVE TRUST: Pet owners will value your commitment to their pet’s health with such state-of-the-art diagnostics.
• INCREASE REVENUE: Offer more treatment options and earlier relapse detection, enhancing both patient outcomes and clinic revenue.

Box: 1 set